Cost-effectiveness of prophylaxis with palivizumab among high-risk children in Hong Kong: abridged secondary publication
Hong Kong Med J
.
2023 Dec;29 Suppl 7(6):37-38.
Authors
P Wu
1
,
B J Cowling
1
,
S S Chiu
2
,
I O L Wong
1
,
W K Y Yeung
3
Affiliations
1
School of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
2
Department of Paediatrics and Adolescent Medicine, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
3
Department of Paediatrics and Adolescent Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China.
PMID:
38148655
No abstract available